Breast cancer, early
Invited discussant LBA13 and abstract 144O
Date
07 Oct 2016Session
Breast cancer, earlyPresenters
Marco ColleoniAuthors
M. ColleoniAuthor affiliations
- Istituto Europeo di Oncologia, 20141 - Milano/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
3802 - Outcome disparities by age and 21-gene recurrence score® (RS) result in hormone receptor positive (HR+) breast cancer (BC)
Presenter: Steven Shak
Session: Breast cancer, early
Resources:
Abstract
Slides
Invited discussant abstracts 145O and 146O
Presenter: Nadia Harbeck
Session: Breast cancer, early
Resources:
Slides
1351 - Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort
Presenter: Xavier Pivot
Session: Breast cancer, early
Resources:
Abstract
Slides
3576 - Prognostic role for derived neutrophil-to-lymphocyte ratio in early breast cancer
Presenter: Alberto Ocana Fernandez
Session: Breast cancer, early
Resources:
Abstract
Slides
1602 - Interim results from neoMONARCH: A neoadjuvant phase II study of abemaciclib in postmenopausal women with HR + /HER2- breast cancer (BC)
Presenter: Sara Hurvitz
Session: Breast cancer, early
Resources:
Abstract
3040 - First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) result
Presenter: Salomon Stemmer
Session: Breast cancer, early
Resources:
Abstract
1206 - Analysis of Oncotype DX recurrence score and its clinical implications in invasive lobular carcinomas of the breast
Presenter: Cristina Truica
Session: Breast cancer, early
Resources:
Abstract
3815 - Prognostic impact of proliferation for resected early stage breast cancer according to histology: Cut-off analysis of Ki67 in 859 patients with pure invasive lobular and ductal breast carcinoma (ILC/IDC)
Presenter: Luisa Carbognin
Session: Breast cancer, early
Resources:
Abstract
4013 - Breast cancer-specific survival in >4,600 patients with lymph node-positive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene recurrence score® (RS) results in the SEER registries
Presenter: Dave Miller
Session: Breast cancer, early
Resources:
Abstract
3308 - Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
Presenter: Antonino Musolino
Session: Breast cancer, early
Resources:
Abstract